Harnessing the therapeutic potential of a novel class of human peptides

Transformational work from Velia founders revealed that many previously overlooked peptides regulate biological functions vital to human health. Velia will discover and develop therapeutics targeting these novel regulators.

LEADERSHIP TEAM

Velia Leadership and Founders

We are translating biological insights into transformative therapeutics. We are excited to unveil important, new biology.

President and CEO
John McHutchison, AO, MD
Read Bio
Chief Business Officer
Michael York
Read Bio
Read Bio
Co-Founder
Eric Olson, PhD
Read Bio
Co-Founder
Alan Saghatelian, PhD
Read Bio
Co-Founder
Richard Scheller, PhD
Read Bio
Co-Founder
Jonathan Weissman, PhD
investors
This team is proudly supported with capital, advisors, and resources from The Column Group & Foresite Capital.

We’re discovering something new. Come join us!

If you are interested in helping build a transformative research company, Velia is an ideal opportunity.  Our passion for innovation and discovery is what drives us.

Job Openings
© 2022 Velia, Inc. All rights reserved